Microanalysis of amoxicillin, flucloxacillin, and rifampicin in neonatal plasma

Biomedical Chromatography

Volumn 21, Issue 12, 2007, Pages 1259-1265

  Pullen, Joyce ^a   Stolk, L M L ^a   Neef, C ^a   Zimmermann, L J I ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Amoxicillin; Antibiotics; Flucloxacillin; HPLC assay; Liquid chromatography; Neonatal plasma; Rifampicin

Indexed keywords

ASSAYS; DICHLOROMETHANE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PATIENT MONITORING;

AMOXICILLIN; FLUCLOXACILLIN; HPLC ASSAY; LIQUID CHROMATOGRAPHIC ASSAY; NEONATAL PLASMA; PHARMACOKINETIC STUDIES; REVERSED-PHASE HIGH PERFORMANCE; RIFAMPICIN; SIMPLE++; ULTRA VIOLET DETECTION;

PHARMACOKINETICS;

AMOXICILLIN; FLUCLOXACILLIN; RIFAMPICIN;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG ANALYSIS; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MICROANALYSIS; NEWBORN; REVERSED PHASE LIQUID CHROMATOGRAPHY;

EID: 38049074235     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.881     Document Type: Article

References (28)

1. Bloemhof H, IJmker J and Uges DRA. De bepaling van enige xenobiotica in lichaamsvloeistoffen (The determination of some xenobiotics in body fluids). Ziekenhuisfarmacie 1988; 4: 137.
2. Chandi LS, Sijs van der IH and Guchelaar HJ. Bepaling van rifampicine en desacetylrifampicine (Determination of rifampicin and desacetylrifampicin). Ziekenhuisfarmacie 1998; 14: 71-72.
3. Charles BG, Foo CC and Gath J. Rapid column liquid chromatographic analysis of flucloxacillin in plasma on a microparticulate pre-column. Journal of Chromatography B, Biomedical Applications 1994; 660: 186-190.
4. Daly JS, Dodge RA, Glew RH, Keroack MA, Bednarek FJ and Whalen M. Effect of time and temperature on inactivation of aminoglycosides by ampicillin at neonatal dosages. Journal of Perinatology 1997; 17: 42-45.
5. Herngren L. Flucloxacillin kinetics in newborn infants. European Journal of Clinical Pharmacology 1989; 36: 325.
6. Herngren L, Ehrnebo M and Broberger U. Pharmacokinetics of free and total flucloxacillin in newborn infants. European Journal of Clinical Pharmacology 1987; 32: 403-409.
7. Hoizey G, Lamiable D, Frances C, Trenque T, Kaltenbach M, Denis J and Millart H. Simultaneous determination of amoxicillin and clavulanic acid in human plasma by HPLC with UV detection. Journal of Pharmaceutical and Biomedical Analysis 2002; 30: 661-666.
8. Huisman-de Boer JJ, Anker van den JN, Vogel M, Goessens WH, Schoemaker RC and Groot de R. Amoxicillin pharmacokinetics in preterm infants with gestational ages of less than 32 weeks. Anti-microbial Agents and Chemotherapy 1995; 39: 431-434.
9. Hung CT, Lira JK, Zoest AR and Lam FC. Optimization of high-performance liquid chromatographic analysis for isoxazolyl penicillins using factorial design. Journal of Chromatography 1988; 425: 331-341.
10. Ishii M and Ogata H. Determination of rifampicin and its main metabolites in human plasma by high-performance liquid chromatography. Journal of Chromatography 1988; 426: 412-416.
11. Jalling B, Malmborg AS, Lindman A and Boreus LO. Evaluation of a micromethod for determination of antibiotic concentrations in plasma. European Journal of Clinical Pharmacology 1972; 4: 150-157.
12. Jelliffe RW. Effect of assumptions concerning assay error patterns upon pharmacokinetic parameter values and model behavior. Journal of Veterinary Pharmacology and Therapeutics 1994; 17: 85-119.
13. Le Guellec C, Gaudet ML, Lamanetre S and Breteau M. Stability of rifampin in plasma: consequences for therapeutic monitoring and pharmacokinetic studies. Therapeutic Drug Monitoring 1997; 19: 669-674.
14. Lin JC, Strauss RG, Kulhavy JC, Johnson KJ, Zimmerman MB, Cress GA, Connolly NW and Widness JA. Phlebotomy overdraw in the neonatal intensive care nursery. Pediatrics 2000; 106: E19.
15. Lindegårdh N, Singtoroj T, Annerberg A, White NJ and Day NP. Development and validation of a solid-phase extraction-liquid chromatographic method for determination of amoxicillin in plasma. Therapeutic Drug Monitoring 2005; 27: 503-508.
16. Mascher HJ and Kikuta C. Determination of amoxicillin in human serum and plasma by high-performance liquid chromatography and on-line postcolumn derivatisation. Journal of Chromatography A 1998; 812: 221-226.
17. Oldfield S, Berg JD, Stiles HJ and Buckley BM. Measurement of rifampicin and 25-desacetylrifampicin in biological fluids using high-performance liquid chromatography with direct sample injection. Journal of Chromatography 1986; 377: 423-429.
18. Peloquin CA. Rifampin stability. Therapeutic Drug Monitoring 1998; 20: 450-451.
19. Pullen J, Rozario de L, Stolk LML, Degraeuwe PLJ, Tiel van FH and Zimmermann LJI. Population pharmacokinetics and dosing of flucloxacillin in preterm and term neonates. Therapeutic Drug Monitoring 2006a; 28: 351-358.
20. Pullen J, Stolk LML, Degraeuwe PLJ, Tiel van FH, Neef C and Zimmermann LJI. Pharmacokinetics of intravenous rifampicin (rifampin) in neonates. Therapeutic Drug Monitoring 2006b; 28: 654-661.
21. Pullen J, Stolk LML, Nieman FHM, Degraeuwe PLJ, Tiel van FH and Zimmermann LJI. Population pharmacokinetics and dosing of amoxicillin in (pre)term neonates. Therapeutic Drug Monitoring 2006c; 28: 226-231.
22. Ratti B, Parenti RR, Toselli A and Zerilli LF. Quantitative assay of rifampicin and its main metabolite 25-desacetylrifampicin in human plasma by reversed-phase high-performance liquid chromatography. Journal of Chromatography 1981; 225: 526-531.
23. Riff LJ and Thomason JL. Comparative aminoglycoside inactivation by beta-lactam antibiotics. Effects of a cephalosporin and six penicillins on five aminoglycosides. The Journal of Antibiotics (Tokyo) 1982; 35: 850-857.
24. Shah VP, Midha KK, Dighe S, McGilveray IJ, Skelly JP, Yacobi A, Layloff T, Viswanathan CT, Cook CE, McDowall RD, Pittman KA and Spector S. Analytical methods validation: bioavailability, bioequivalence, and pharmacokinetic studies. Journal of Pharmaceutical Sciences 1992; 81: 309-312.
25. Sutherland R, Croydon EAP and Rolinson GN. Flucloxacillin, a new isoxazolyl penicillin, compared with oxacillin, cloxacillin, and dicloxacillin. British Medical Journal 1970; 4: 455-460.
26. Tan TQ, Mason EO, Ou CN and Kaplan SL. Use of intravenous rifampin in neonates with persistent staphylococcal bacteremia. Antimicrobial Agents and Chemotherapy 1993; 37: 2401-2406.
27. Thijssen HHW. Analysis of isoxazolyl penicillins and their metabolites in body fluids by high-performance liquid chromatography. Journal of Chromatography. B, Biomedical Applications 1980; 183: 339-345.
28. Tindula RJ, Ambrose PJ and Harralson AF. Aminoglycoside inactivation by penicillins and cephalosporins and its impact on drug-level monitoring. Drug Intelligence and Clinical Pharmacy 1983; 17: 906-908.